Top 5 Barriers To Scalable ncAA Conjugation And What's Finally Changing

Non-canonical amino acid conjugation offers a precise, controlled approach to modifying therapeutic proteins. Still, for most programs, the path from proof of concept to scalable process has been blocked by the same recurring problems: yield loss at fermentation scale, host toxicity, incomplete incorporation, and site selection that compromises function.

Recent data from an anti-GPCR VHH program running in a Pseudomonas fluorescens expression system shows those barriers can be cleared. Using a continuous pAzF feed strategy, the program achieved titers near 15 g/L, comparable to canonical VHH, while demonstrating 100% incorporation at Y84 and full click reaction conversion. HDX-MS-guided site selection preserved binding affinity post-conjugation.

The data points to a consistent finding: yield loss and incorporation failures are not inherent to ncAA chemistry. They reflect process gaps that can be addressed. Read the full article to see what it takes.